• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Iovance Biotherapeutics Inc (NQ: IOVA )

    8.690 +0.360 (+4.32%)
    Official Closing Price Updated: 4:15 PM EDT, Jul 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,949,676
    Open 8.230
    Bid (Size) 8.700 (50)
    Ask (Size) 8.730 (3)
    Prev. Close 8.330
    Today's Range 8.210 - 8.785
    52wk Range 3.210 - 18.33
    Shares Outstanding 279,832,722
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    How Is The Market Feeling About Iovance Biotherapeutics?
    Via Benzinga

    Performance

    YTD
    +7.28%
    +7.28%
    1 Month
    +6.50%
    +6.50%
    3 Month
    -23.23%
    -23.23%
    6 Month
    +7.55%
    +7.55%
    1 Year
    +17.91%
    +17.91%

    More News

    Read More
    Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    7 ‘Death Cross’ Stocks That Could Be Contrarian Buys
    Via InvestorPlace
    What's Going On With Iovance Biotherapeutics Today?
    Via Benzinga
    Iovance Biotherapeutics's Options: A Look at What the Big Money is Thinking
    Via Benzinga
    Is Iovance Biotherapeutics a Millionaire Maker?
    Via The Motley Fool
    3 Under-$10 Biotech Stocks That Could Make You Rich
    Via InvestorPlace
    Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    Is It Too Late to Buy Iovance Biotherapeutics Stock?
    Via The Motley Fool
    Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    3 Top Penny Stocks to Skyrocket Your Wealth in 2024
    Via InvestorPlace
    The Case for Buying Iovance Biotherapeutics Stock Just Got Even Better. Here's Why
    Via The Motley Fool
    Oncotelic Therapeutics (OTC: OTLC) Inks Deal With Mosaic ImmunoEngineering To Sell Clinical-Stage Necroptosis Cancer Therapy Assets
    Via News Direct
    Exposures Product Safety
    Iovance Biotherapeutics to Present at Upcoming Conferences and Events
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    Bull Market Buys: 2 Growth Stocks to Own for the Long Run
    Via The Motley Fool
    Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    4 Small-Cap Value Stocks That Could Go Parabolic
    Via The Motley Fool
    The 3 Most Undervalued Biotech Stocks to Buy in May 2024
    Via InvestorPlace
    Why Iovance Stock Is Down 18% Today
    Via The Motley Fool
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.